PropertyValue
rdfs:label
  • Osteoarthritis
rdfs:comment
  • Many people erroneously think that OA is due to wear and tear. This common misconception is due to the fact that OA typically does not present in younger people. Abnormal loading of joints due to poor posture may increase risk for OA, but only because of the abnormal loading of the joint. If a joint is loaded normally, there should be no OA - the coefficient of friction of a normal joint is frequently described as sliding ice on ice - it will go forever.
owl:sameAs
dcterms:subject
mortalityrate
  • N/A
symptom
  • Pain and stiffness in knees or elbows
dbkwik:house/property/wikiPageUsesTemplate
Name
  • Osteoarthritis
Type
treatment
Cause
  • Breakdown of cartilage
abstract
  • Many people erroneously think that OA is due to wear and tear. This common misconception is due to the fact that OA typically does not present in younger people. Abnormal loading of joints due to poor posture may increase risk for OA, but only because of the abnormal loading of the joint. If a joint is loaded normally, there should be no OA - the coefficient of friction of a normal joint is frequently described as sliding ice on ice - it will go forever. OA affects nearly 21 million people in the United States, accounting for 25% of visits to primary care physicians, and half of all NSAID (Non-Steroidal Anti-Inflammatory Drugs) prescriptions. It is estimated that 80% of the population will have radiographic evidence of OA by age 65, although only 60% of those will be symptomatic. Treatment is with NSAIDs, local injections of glucocorticoid or hyaluronan, and in severe cases, with joint replacement surgery. There has been no cure for OA, as cartilage has not been induced to regenerate. However, if OA is caused by cartilage damage (for example as a result of an injury) Chondrocyte Implantation may be a possible treatment. Clinical trials employing tissue-engineering methods have demonstrated regeneration of cartilage in damaged knees, including those that had progressed to osteoarthritis. Further, in January 2007, Johns Hopkins University was offering to license a technology of this kind, listing several clinical competitors in its market analysis.